Enzo Biochem Inc/ US2941001024 /
| 30/05/2024 22:10:00 | Chg. -0.09 | Volume | Bid13:37:56 | Ask13:37:56 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1.16USD | -7.20% | 339,772 Turnover: 399,717.07 |
1.11Bid Size: 3,500 | 1.20Ask Size: 200 | 59.42 mill.USD | - | 2.83 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 0.41 USD | - |
| EPS Diluted: | 0.41 USD | - |
| Revenues per Share: | 0.62 USD | -72.01% |
| Book Value per Share: | 1.55 USD | 39.02% |
| Cash Flow per Share: | -0.73 USD | 115.07% |
| Dividend per Share: | - USD | - |
| Total | in mill. | |
| Revenues: | 31.06 USD | -70.99% |
| Net Income: | 20.29 USD | - |
| Operating Cash Flow: | -36.98 USD | - |
| Cash and Cash Equivalents: | 82.37 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 2.83 | 3.61 |
| P/S Ratio: | 1.89 | 2.41 |
| P/BV ratio: | 0.75 | 0.95 |
| P/CF Ratio: | -1.58 | -2.02 |
| PEG: | - | - |
| Earnings Yield: | 35.34% | 27.70% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 59.42 mill. USD | 74.72 mill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 51.23 mill. | |
Profitability
| Gross Profit Margin: | 42.48% |
| EBIT Margin: | -79.64% |
| Net Profit Margin: | 65.32% |
| Return on Equity: | 25.86% |
| Return on Assets: | 16.65% |
Financial Strength
| Liquidity I / Cash Ratio: | 205.99% |
| Liquidity II / Quick Ratio: | 218.01% |
| Liquidity III / Current Ratio: | 246.21% |
| Debt / Equity Ratio: | 55.34% |
| Dynam. Debt / Equity Ratio: | -117.42% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 31/07/2023 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
